Hillenbrand Inc. has announced the sale of a 51% stake in its Milacron injection molding and extrusion business to an ...

Q1 2025 Management View CEO Kimberly Ryan highlighted the sale of a 51% stake in the Milacron injection molding and extrusion business to Bain Capital for $287 million, retaining a 49% stake. This ...

Hillenbrand Inc. has announced plans to sell a 51 percent stake in its Cincinnati-based subsidiary Milacron LLC, to an affiliate of Boston-based investment firm Bain Capital. Hillenbrand, which is ...

The provider of highly-engineered processing equipment and solutions will sell a 51% stake in the injection molding and extrusion business for $287 million.

Hillenbrand Inc. decided to sell a majority stake in its Milacron plastics machinery business rather than a full divestiture following a portfolio review, President and CEO Kim Ryan said.